-
Study aim
-
This study was a randomized, double blind clinical trial. 400 patients with open heart surgery candidates were randomly divided into two groups, with and without (control) amiodarone. Finally, the prevalence of cardiac arrhythmias after surgery until the patient's stay in the intensive care unit is recorded in the questionnaires.
-
Design
-
A concealed, randomized, blinded, sham controlled clinical trial with a parallel group design of 501 patients, enrolled between April 2016 and March 2018, and followed for one year
-
Settings and conduct
-
In the intervention group, 200 mg of amiodarone was given orally twice a day until the patient was cleared. Patients in the control group received placebo (vitamin B1). The frequency and duration of use of placebo in the control group were completely similar to the oral administration of amiodarone in the intervention group. Electrocardiogram monitoring was conducted continuously and monitored.
-
Participants/Inclusion and exclusion criteria
-
Age over 18 years, [pen heart surgery, Sinus rhythm and normal function of liver, renal system , pulmonary system and thyroid.
History of atrial and ventricular arrhythmia and cardiac blocks, patient's need for Pace, anti-arrhythmic therapy, Age over 80 years, pregnant patients
-
Intervention groups
-
In the intervention group, 200 mg of amiodarone was given orally twice a day until the patient was cleared. Patients in the control group received placebo (vitamin B1). The frequency and duration of use of placebo in the control group were completely similar to the oral administration of amiodarone in the intervention group.
-
Main outcome variables
-
Incidence of types of arrhythmia, duration of admission to ICU, hospitalization time and side effects of amiodarone